Keiichiro Yamane

977 total citations
9 papers, 92 citations indexed

About

Keiichiro Yamane is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Keiichiro Yamane has authored 9 papers receiving a total of 92 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 3 papers in Pharmacology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Keiichiro Yamane's work include Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Inflammatory mediators and NSAID effects (3 papers) and Heart Failure Treatment and Management (2 papers). Keiichiro Yamane is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Inflammatory mediators and NSAID effects (3 papers) and Heart Failure Treatment and Management (2 papers). Keiichiro Yamane collaborates with scholars based in Japan. Keiichiro Yamane's co-authors include Tomoyuki Ikeda, Ryoji Taniguchi, Hisanori Horiuchi, Takeshi Kimura, Tadashi Miyamoto, Yoshihiro Kato, Junichi Tazaki, Kiyoto Nishi, Toshikazu Jinnai and Tomohisa Tada and has published in prestigious journals such as American Heart Journal, Circulation Journal and Journal of Atherosclerosis and Thrombosis.

In The Last Decade

Keiichiro Yamane

9 papers receiving 87 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keiichiro Yamane Japan 6 60 18 16 15 14 9 92
Merav Ingbir Israel 8 74 1.2× 13 0.7× 25 1.6× 8 0.5× 6 0.4× 18 147
Alp Burak Çatakoğlu Türkiye 7 70 1.2× 34 1.9× 10 0.6× 23 1.5× 7 0.5× 14 112
Toishi Sharma United States 4 21 0.3× 26 1.4× 11 0.7× 15 1.0× 7 0.5× 16 92
Т. Е. Морозова Russia 5 44 0.7× 17 0.9× 4 0.3× 7 0.5× 8 0.6× 62 105
Asma Khaliq United States 5 71 1.2× 45 2.5× 17 1.1× 20 1.3× 27 1.9× 10 153
Mohamad Sinno United States 7 121 2.0× 29 1.6× 9 0.6× 31 2.1× 6 0.4× 13 160
Xando Díaz-Villamarín Spain 9 69 1.1× 36 2.0× 24 1.5× 26 1.7× 15 1.1× 17 161
Takahiko Kinjo Japan 9 281 4.7× 15 0.8× 21 1.3× 7 0.5× 5 0.4× 34 320
Davide Bernucci Italy 7 56 0.9× 50 2.8× 6 0.4× 22 1.5× 8 0.6× 12 149

Countries citing papers authored by Keiichiro Yamane

Since Specialization
Citations

This map shows the geographic impact of Keiichiro Yamane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiichiro Yamane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiichiro Yamane more than expected).

Fields of papers citing papers by Keiichiro Yamane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiichiro Yamane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiichiro Yamane. The network helps show where Keiichiro Yamane may publish in the future.

Co-authorship network of co-authors of Keiichiro Yamane

This figure shows the co-authorship network connecting the top 25 collaborators of Keiichiro Yamane. A scholar is included among the top collaborators of Keiichiro Yamane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiichiro Yamane. Keiichiro Yamane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Yamane, Keiichiro, Tomoyuki Ikeda, Ryoji Taniguchi, et al.. (2012). Impact of Platelet Reactivity on Long-term Clinical Outcomes and Bleeding Events in Japanese Patients Receiving Antiplatelet Therapy with Aspirin. Journal of Atherosclerosis and Thrombosis. 19(12). 1142–1153. 6 indexed citations
2.
Yamane, Keiichiro, Yoshihiro Kato, Junichi Tazaki, et al.. (2012). Effects of PPIs and an H2 blocker on the Antiplatelet Function of Clopidogrel in Japanese Patients under Dual Antiplatelet Therapy. Journal of Atherosclerosis and Thrombosis. 19(6). 559–569. 23 indexed citations
3.
Tazaki, Junichi, Toshikazu Jinnai, Tomohisa Tada, et al.. (2011). Prediction of Clopidogrel Low Responders by a Rapid CYP2C19 Activity Test. Journal of Atherosclerosis and Thrombosis. 19(2). 186–193. 14 indexed citations
4.
Yamada, S., et al.. (2010). High-quality ferromagnetic CoFe/Si contacts for Si spin-transistor applications. 40. 1872–1874. 1 indexed citations
5.
Ikeda, Tomoyuki, Ryoji Taniguchi, Shin Watanabe, et al.. (2010). Characterization of the Antiplatelet Effect of Aspirin at Enrollment and After 2-Year Follow-up in a Real Clinical Setting in Japan. Circulation Journal. 74(6). 1227–1235. 5 indexed citations
6.
Sato, Yukihito, Kiyoto Nishi, Ryoji Taniguchi, et al.. (2009). In patients with heart failure and non-ischemic heart disease, cardiac troponin T is a reliable predictor of long-term echocardiographic changes and adverse cardiac events. Journal of Cardiology. 54(2). 221–230. 28 indexed citations
7.
Sato, Yukihito, Tadashi Miyamoto, Ryoji Taniguchi, et al.. (2008). The clinical and hemodynamic factors that influence the concentrations of biomarkers of myocyte injury measured by high sensitive assay PATHFAST. Journal of Cardiology. 53(1). 20–27. 9 indexed citations
8.
NISHIDA, Masahiro, T Shima, Yôko Okada, et al.. (1998). [Macroscopic and pathohistological investigation of endarterial plaque after intraoperative balloon dilatation of the carotid artery during carotid endarterectomy].. PubMed. 26(12). 1075–82. 1 indexed citations
9.
Yamane, Keiichiro, et al.. (1972). The congenital cardiovascular anomalies of the interruption of the aorta-Steidel's complex. American Heart Journal. 83(1). 93–99. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026